Business Wire

Global Endotoxin Testing Industry (2021 to 2029) – Investment in Medical Devices Propelling Market Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Endotoxin Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029” report has been added to ResearchAndMarkets.com’s offering.

The global endotoxin testing market is developing significantly with an expected CAGR of 8.5% from 2019 – 2029. Advances in technological processes are the key growth factor.

Investment in Medical Devices Propelling Market Growth

The transition of medical device industry post the medical outsourcing has led to increased avenues in the developing economies as a result of increased and favorable public initiatives, regulations and increased market penetration for medical devices. Apart from widening scope of medical devices there has been tremendous growth and advances in automation of data entry, data management and reporting. Emerging technological advancement withrespect to laboratory testing has expanded the demand in Europe and Asia pacific.

The key methods included in the endotoxin testing include turbidimetric method, gel clot method and custom method development. The key application areas include medical device manufacturing, pharmaceutical manufacturing, packaging manufacture and raw materials production. Advancements in products offering strong linearity and high sensitivity with reproducibility have led to higher revenues across the globe. Increasing developments withrespect to the entire healthcare industry and its infrastructure and emerging regulatory framework in developing economies such as China and India are expected to increase market revenues. However there is high cost involved in endotoxicin testing systems, apart from complexity in low endotixin recovery and stringent regulation in animal testing are expected to hamper the development in the market during the forecast period.

LAL Test Leads the Current and the Future Market

The endotoxin test uses methods such as Limulus amoeba cell lysate (LAL), rabbit pyrogen test (RPT), monocyte activation test (MAT), and recombinant factor C test, are deployed in the endotoxin testing. The LAL method has been used in pyrogen testing for over 30 years to detect endotoxins and is still expected to witness highest CAGR during the forecast period of 2019 to 2029. Monocyte activation testing is an in vitro method, is a comparatively newer method in the industry.

Companies Mentioned

  • ToxinSensorT
  • PyroMATT System
  • Kinetic-QCLTM Kinetic Chromogenic LAL Assay
  • PYROGENTTM Gel Clot LAL Assay
  • Accugen Labs
  • Wako Chemicals USA Inc.
  • Charles River Laboratories Inc.
  • Pacific BioLabs
  • Sigma-Aldrich Co. LLC. Lonza
  • STERIS
  • Nelson Laboratories LLC
  • Bio-Synthesis Inc
  • Biogenuix
  • Ellab A/S
  • GenScript Corporation
  • Thermo Fisher Scientific Inc.
  • Merck KGaA

Key questions answered in this report

  • What are the key market segments in current scenario and in the future by product categories
  • What are the key market segments in current scenario and in the future by regions
  • What is the key impact of Covid 19 over market revenues and market determinants in the medical aesthetics market?
  • What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
  • What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
  • How to overcome the current market challenges and leverage the opportunities in each of the market segment?
  • Who are the key players in the medical aesthetics market and what are their key product categories and strategies?
  • What are the key strategies – mergers/acquisitions/R&D/strategic partnerships etc that companies are deploying to enhance market revenues and growth?

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Global Endotoxin Testing (ET) Market: Market Dynamics and Future Outlook

3.1. Market Overview

3.2. Current Scenario: New Product Launches, Increase in Animal Free Testing

3.3. Drivers

3.4. Challenges

3.5. Opportunities

3.6. Attractive Investment Proposition, by Geography, 2020

3.7. Competitive Landscape

3.7.1. Competitive Landscape, by Key Players, 2020

Chapter 4. Global Endotoxin Testing (ET) Market, by Product Type, 2019 – 2029 (US$ Mn)

4.1. Overview

4.2. Endotoxin Detection Kits & Reagents

4.3. Instruments & Systems

4.4. Consumables & Accessories

Chapter 5. Global Endotoxin Testing (ET) Market, by Test Type, 2019 – 2029 (US$ Mn)

5.1. Overview

5.2. LAL Test

5.2.1. Chromogenic Tests

5.2.2. Turbidimetric Tests

5.2.3. Gel Clot Tests

5.3. MAT Test

5.4. Rabbit Pyrogen Test

5.5. Recombinant Factor C (rFC) Assay

Chapter 6. Global Endotoxin Testing (ET) Market, by Application, 2019 – 2029 (US$ Mn)

6.1. Overview

6.2. Medical Device Manufacturing

6.3. Pharmaceutical Manufacturing

6.4. Raw Materials Production

Chapter 7. Global Endotoxin Testing (ET) Market, by Geography, 2019 – 2029 (US$ Mn)

7.1. Overview

7.2. North America ET Market Analysis, 2019 – 2029

7.3. Europe ET Market Analysis, 2019 – 2029

7.4. Asia Pacific ET Market Analysis, 2019 – 2029

7.5. Latin America ET Market Analysis, 2019 – 2029

7.6. Middle East & Africa (MEA) ET Market Analysis, 2019 – 2029

Chapter 8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/6dbqjh

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button